Use of this site indicates acceptance of these terms.
Zepbound, Semaglutide, and Wegovy all serve similar functions in chronic weight management, with Semaglutide being the active ingredient in Wegovy, differentiating it from Zepbound
Nevi of skin that have uniform color and borders and are not changing in size or surface texture are not considered premalignant lesions and do not need to be removed unless they are chronically irritated or are a cosmetic problem
Phase III, PIONEER Program Multiple phase III efficacy trials have been fully published and/or presented in abstract form
Only 4-7% of participants in SURMOUNT-1 and 2 discontinued the medication due to AE (Tables 2, 3)
That is the realistic guardrail that keeps the protocol producing the response patients paid for, without asking them to disappear socially for 12 weeks